MICM
KRRO icon

Matthews International Capital Management’s Korro Bio KRRO Stock Holding History

Matthews International Capital Management’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-9,529
Closed -$16.8M – 54
2020
Q4 		$16.8M Hold
9,529
– – 0.89% 24
2020
Q3 		$9.15M Hold
9,529
– – 0.62% 23
2020
Q2 		$11.1M Buy
9,529
+787
+9% +$711K 0.86% 22
2020
Q1 		$7.78M Hold
8,742
– – 0.5% 23
2019
Q4 		$7.66M Buy
+8,742
New +$6.8M 0.37% 23

Other funds holding KRRO

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Matthews International Capital Management's KRRO Position: Q1 2021 in Review

Matthews International Capital Management sold out of Korro Bio (KRRO) in Q1 2021, closing a stake of 9,529 shares — an estimated $16.8M sold.

Matthews International Capital Management first reported a position in KRRO in Q4 2019 and held it in 5 quarters. The position peaked at $16.8M in Q4 2020. 115 funds tracked by Wall St. Rank hold KRRO as of Q1 2021.

  • Matthews International Capital Management reported no remaining Korro Bio position as of Q1 2021 after selling out during the quarter.
  • Matthews International Capital Management sold 9,529 Korro Bio shares in Q1 2021, an estimated $16.8M.
  • Matthews International Capital Management first reported a position in Korro Bio in Q4 2019 and held it in 5 quarters.
  • Matthews International Capital Management's Korro Bio position peaked at $16.8M in Q4 2020.
  • 115 funds tracked by Wall St. Rank held Korro Bio as of Q1 2021.

Based on Matthews International Capital Management's 13F filing for Q1 2021, filed 6 May 2021.